<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04989933</url>
  </required_header>
  <id_info>
    <org_study_id>AtaturkU-AnkaraCH</org_study_id>
    <secondary_id>Asli Demir</secondary_id>
    <secondary_id>Ali Ahiskalioglu</secondary_id>
    <nct_id>NCT04989933</nct_id>
  </id_info>
  <brief_title>Erector Spinae Plane Block With Two Different Volume for Open Heart Surgery</brief_title>
  <acronym>ESP</acronym>
  <official_title>Ultrasound Guided Erector Spinae Plane Block With Two Different Volume for Open Heart Surgery: Randomized Controlled Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ataturk University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ataturk University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The erector spine plane block is currently used in many surgeries to provide postoperative&#xD;
      analgesia. It has also been used successfully in open-heart surgery for postoperative&#xD;
      sternotomy pain. However, an ideal volume that will provide optimum analgesia has not yet&#xD;
      been determined.&#xD;
&#xD;
      This study aims to compare the effects of ESP block administered in two different volumes on&#xD;
      poststernotomy pain.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">August 2, 2021</start_date>
  <completion_date type="Anticipated">November 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">November 1, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Rescue analgesia</measure>
    <time_frame>Post-extubation 24 hours</time_frame>
    <description>Total amount of rescue analgesic</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Sternotomy Pain</condition>
  <arm_group>
    <arm_group_label>ESP 20 ml</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Ultrasound-Guided erector spinae plane block with 20 ml of 0.25% bupivacaine</description>
  </arm_group>
  <arm_group>
    <arm_group_label>ESP 30 ml</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Ultrasound-Guided erector spinae plane block with 30 ml of 0.25% bupivacaine</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Ultrasound-guided erector spinae plane block</intervention_name>
    <description>Ultrasound-Guided erector spinae plane block with 0.25% bupivacaine</description>
    <arm_group_label>ESP 20 ml</arm_group_label>
    <arm_group_label>ESP 30 ml</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  American Society of Anesthesiologist's physiologic state I-III patients Undergoing&#xD;
             Open Heart Surgery&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  chronic pain bleeding disorders renal or hepatic insufficiency patients on chronic&#xD;
             non-steroidal anti-inflammatory medications emergency cases&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>July 31, 2021</study_first_submitted>
  <study_first_submitted_qc>July 31, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">August 4, 2021</study_first_posted>
  <last_update_submitted>July 31, 2021</last_update_submitted>
  <last_update_submitted_qc>July 31, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 4, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ataturk University</investigator_affiliation>
    <investigator_full_name>Ali Ahiskalioglu</investigator_full_name>
    <investigator_title>Assoc. Prof.</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

